Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease - The Vienna RAP Study

NCT02055079 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT02055079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02055079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease - The Vienna RAP Study
Lead sponsor
Medical University of Vienna
Phase
Phase 3
Overall status
Unknown status
Start date
April 30, 2014
Completion date
December 31, 2019
Enrollment
68 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

polycystic kidney, type 1 autosomal dominant disease, polycystic kidney, type 2 autosomal dominant disease